Show simple item record

The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients

dc.contributor.authorKaradag, S. G.
dc.contributor.authorOzdel, S.
dc.contributor.authorYener, G. Otar
dc.contributor.authorDemir, F.
dc.contributor.authorOzturk, K.
dc.contributor.authorCakan, M.
dc.contributor.authorAyaz, N. Aktay
dc.contributor.authorBaglan, E.
dc.contributor.authorSozeri, B.
dc.contributor.authorSonmez, H. E.
dc.date.accessioned2021-12-10T10:10:39Z
dc.date.available2021-12-10T10:10:39Z
dc.date.issued2021
dc.identifier.citationSozeri B., Sonmez H. E. , Karadag S. G. , Baglan E., Ozturk K., Cakan M., Demir F., Yener G. O. , Ozdel S., Ayaz N. A. , "The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients", CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, cilt.39, sa.5, 2021
dc.identifier.issn0392-856X
dc.identifier.othervv_1032021
dc.identifier.otherav_2e001a4f-8659-4e0d-b5c3-b0c4aa60fdb9
dc.identifier.urihttp://hdl.handle.net/20.500.12627/169353
dc.description.abstractObjective. To determine the feasibility of withdrawing canakinumab (CAN) in a large cohort of paediatric patients with colchicine-resistant familial Mediterranean fever (crFMF).
dc.language.isoeng
dc.subjectROMATOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectİmmünoloji ve Romatoloji
dc.subjectRheumatology
dc.subjectHealth Sciences
dc.titleThe feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients
dc.typeMakale
dc.relation.journalCLINICAL AND EXPERIMENTAL RHEUMATOLOGY
dc.contributor.departmentUniv Hlth Sci , ,
dc.identifier.volume39
dc.identifier.issue5
dc.contributor.firstauthorID2755379


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record